The novel N-type calcium channel blocker, AM336, produces potent dose-dependent antinociception after intrathecal dosing in rats and inhibits substance P release …

MT Smith, PJ Cabot, FB Ross, AD Robertson, RJ Lewis - Pain, 2002 - journals.lww.com
N-type calcium channels modulate the release of key pro-nociceptive neurotransmitters
such as glutamate and substance P (SP) in the central nervous system. Considerable …

Therapeutic potential of PKC inhibitors in painful diabetic neuropathy

J Kamei, H Mizoguchi, M Narita… - Expert Opinion on …, 2001 - Taylor & Francis
Diabetic neuropathy accompanied by anomalies in pain perception is one of the most
frequent complications in insulin-dependent diabetes in humans. Many clinical and …

[图书][B] Therapie chronischer Schmerzen: ein praktischer Leitfaden; mit 16 Tabellen

HW Striebel - 2002 - books.google.com
Schmerz ist genauso wie Hunger und Durst ein Urphänomen des Lebens. Während dem
akuten Schmerz eine durchaus sinnvolle und lebenserhaltende Funktion zukommt, fehlt …

The signaling components of sensory fiber transmission involved in the activation of ERK MAP kinase in the mouse dorsal horn

IJ Lever, S Pezet, SB McMahon, M Malcangio - Molecular and Cellular …, 2003 - Elsevier
The stimulation of C-fiber sensory neurons is known to induce activation of the ERK MAP
kinase signaling pathway in the spinal cord dorsal horn. In this study we have elucidated …

Possible involvement of spinal protein kinase C in thermal allodynia and hyperalgesia in diabetic mice

M Ohsawa, J Kamei - European journal of pharmacology, 1999 - Elsevier
We examined the tail-flick response to various heat intensities in diabetic and non-diabetic
mice. Heat intensities were set to one of five values by adjusting the source voltage of a 50 …

Neurokinin release produced by capsaicin acting on the central terminals and axons of primary afferents: relationship with N-methyl-d-aspartate and GABAB receptors

LJ Lao, B Song, JCG Marvizon - Neuroscience, 2003 - Elsevier
Capsaicin stimulates neurokinin release in the spinal cord when applied both centrally and
peripherally. To determine whether these two actions have different mechanisms, we …

Alteration in the brain content of substance P (1–7) during withdrawal in morphine-dependent rats

Q Zhou, Z Liu, A Ray, W Huang, K Karlsson… - Neuropharmacology, 1998 - Elsevier
Previous studies have shown that substance P (SP) may modulate the abstinence reaction
to opioid withdrawal. Its N-terminal fragment SP1–7 may inhibit the intensity of the …

Chelation of zinc in the extracellular area of the spinal cord, using ethylenediaminetetraacetic acid disodium-calcium salt or dipicolinic acid, inhibits the antinociceptive …

AA Larson, KF Kitto - Journal of Pharmacology and Experimental …, 1999 - ASPET
Capsaicin depolarizes primary afferent C-fibers releasing substance P (SP) whose N-
terminal metabolites appear to play a role in the development of antinociception. Because …

Role of intracellular calcium in thermal allodynia and hyperalgesia in diabetic mice

M Ohsawa, J Kamei - Brain research, 1999 - Elsevier
We examined the involvement of cytosolic calcium on thermal hyperalgesia and allodynia
seen in diabetic mice. Tail-flick latencies at source voltages of a 50-W projection bulb to 35 …

Modulation of peripheral inflammation by the substance P N-terminal metabolite substance P1–7

D Wiktelius, Z Khalil, F Nyberg - Peptides, 2006 - Elsevier
The N-terminal metabolite of the undecapeptide substance P (SP), substance P1–7 (SP1–
7), is known to modulate nociception in the central nervous system (CNS) and often has …